INVENTRO S.A.
Investors
Corporate information and documents for shareholders and investors in Inventro S.A.
Documents and announcements
Publication date:
Merger plan for Moonlit S.A. and Inventro S.A.
- Download PDF
Merger plan dated 30 October 2026
PDF · in Polish
About the company
Inventro combines artificial intelligence with experimental biology for drug discovery. We assess compound activity and biological responses in preclinical research, with a focus on oncology.
- Company name
- Inventro S.A.
- Registered city
- Białystok
- KRS
- 0001018511
- NIP
- 5423463201
- REGON
- 524427247
Investor enquiries
For enquiries about the company and its corporate documents, please contact:
contact@inventro.co